AstraZeneca to acquire Neogene Therapeutics for $320m

By NS Healthcare Staff Writer

30 Nov 22

The transaction consideration includes an initial payment of $200m upon closing, and contingent milestones-based and non-contingent consideration of…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

C4X Discovery, AstraZeneca enter $402m partnership focused on COPD treatments

By NS Healthcare Staff Writer

29 Nov 22

AstraZeneca will develop and market an oral therapy for the treatment of inflammatory and respiratory diseases with focus…

PharmaceuticalsPartnerships and Licensing Agreements

Everest Medicines announces regulatory update for Nefecon in Taiwan and South Korea

By NS Healthcare Staff Writer

28 Nov 22

The Taiwan Food and Drug Administration has granted accelerated approval designation (AAD), and South Korea’s Ministry of Food…

PharmaceuticalsRegulation

Hyundai Bioscience to launch clinical trial of Polytaxel in pancreatic cancer

By NS Healthcare Staff Writer

28 Nov 22

The South Korean biotech firm claimed that the anticancer therapy candidate could complete chemotherapy with two doses in…

Clinical trialsPharmaceuticals

Investigational mRNA vaccine shows promise against all 20 flu strains

By NS Healthcare Staff Writer

25 Nov 22

The two-dose vaccine, which leverages the same mRNA technology used in the Covid-19 vaccines developed by Pfizer and…

PharmaceuticalsClinical trials

AbbVie secures EC approval for Skyrizi to treat active Crohn’s disease

By NS Healthcare Staff Writer

24 Nov 22

Skyrizi is a humanised monoclonal antibody inhibitor that selectively targets interleukin-23 (IL-23), a cytokine involved in inflammatory processes,…

PharmaceuticalsRegulation

CSL Behring obtains FDA approval for Hemgenix to treat haemophilia B

By NS Healthcare Staff Writer

23 Nov 22

Hemgenix is a gene therapy that promotes continuous production of factor IX to reduce abnormal bleeding in people…

PharmaceuticalsRegulation

Merck to acquire biopharmaceutical company Imago BioSciences for $1.35bn

By NS Healthcare Staff Writer

22 Nov 22

Merck, through its acquisition subsidiary, will initiate a tender offer to acquire all outstanding shares of Imago for…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Jazz’ Rylaze granted expanded FDA approval for new dosing option

By NS Healthcare Staff Writer

21 Nov 22

The expanded approval adds new dosing options for Rylaze, which provides sustained asparaginase activity for adult and paediatric…

PharmaceuticalsRegulation

Provention Bio secures FDA approval for TZIELD to delay diabetes

By NS Healthcare Staff Writer

18 Nov 22

TZIELD is an anti-CD3-directed antibody, indicated for administration as a once-daily intravenous infusion for 14 days, to delay…

PharmaceuticalsRegulation